Ardelyx
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 3 months.
- Its last 8 Sell calls were actually followed by a +45% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -34.7% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 11.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C-
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 199.2x | Better than 1% |
| Price / Sales | 1.7x | Better than 64% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 90.3% | Better than 97% |
| Operating margin | -10.1% | Better than 15% |
| Net margin | -15.1% | Better than 14% |
| Return on equity | -36.2% | Better than 11% |
| Return on invested capital | -11.5% | Better than 17% |
Momentum D-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -23.1% | Better than 26% |
| 6-month return | -51.1% | Better than 7% |
| 12-month return (ex latest month) | -41.0% | Better than 5% |
| Distance below 52-week high | 64.4% | Better than 8% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.3x | Better than 83% |
| Debt to assets | 41.5% | Better than 25% |
| Interest coverage | -1.1x | Better than 22% |
Analyst View A+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 314.7% | Better than 98% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 3.06
- Open
- 3.01
- Day range
- 2.95 - 3.08
- Avg price
- 3.00
- Volume
- 6.20M
- Turnover
- 18.60M
- Turnover ratei
- 2.88%
- Volume ratioi
- 1.66
- Amplitudei
- 4.25%
- 52-week rangei
- 2.80 - 8.40
Valuation
- P/Ei
- -11.50
- P/E (TTM)i
- -13.00
- P/Bi
- 4.58
- EPSi
- -0.26
- Book value / shi
- 0.65
- Net profit
- -65.36M
- Net assets
- 164.15M
Share structure
- Market cap
- 751.60M
- Float capi
- 644.60M
- Shares out
- 251.37M
- Float sharesi
- 215.59M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
64.4% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+767.56K net over the window
Short interest
- Shares short
- 29.21M
- % of floati
- 11.31%
- Days to coveri
- 7.53
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Ardelyx (ARDX)?
Ardelyx last traded at 2.99. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Ardelyx's market cap?
About 751.60M.
What is the P/E ratio of Ardelyx?
The trailing twelve-month P/E is -13.00. The Valuation tab shows it against the stock's own five-year range.
Does Ardelyx pay a dividend?
Ardelyx does not currently pay a regular dividend.
Is Ardelyx a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 12.40, which implies 314.7% upside from the current price. This is not investment advice.
What is Ardelyx's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Ardelyx a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Ardelyx discussion 0 comments